Quick Answer
Eledon Pharmaceuticals, Inc. reported Research And Development Expense of $66.27 million for the year ending 2025.
- Eledon Pharmaceuticals, Inc. showed an increase of +27.5% in Research And Development Expense from 2024 to 2025.
- This data is from Eledon Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $2.70 million | Q1 2014: $3.56 million | Q2 2014: $4.39 million | Q3 2014: $2.83 million | Q1 2015: $10.56 million | Q2 2015: $5.86 million | Q3 2015: $8.49 million | Q1 2016: $7.93 million | Q2 2016: $592.0 thousand | Q3 2016: $1.05 million | Q1 2017: $479.0 thousand | Q2 2017: $533.0 thousand | Q3 2017: $517.0 thousand | Q1 2018: $1.10 million | Q2 2018: $1.33 million | Q3 2018: $1.65 million | Q1 2019: $2.99 million | Q2 2019: $2.30 million | Q3 2019: $1.51 million | Q1 2020: $1.65 million | Q2 2020: $832.0 thousand | Q3 2020: $615.0 thousand | Q1 2021: $5.65 million | Q2 2021: $4.24 million | Q3 2021: $7.66 million | Q1 2022: $6.64 million | Q2 2022: $5.74 million | Q3 2022: $7.45 million | Q1 2023: $8.11 million | Q2 2023: $7.20 million | Q3 2023: $7.93 million | Q1 2024: $7.41 million | Q2 2024: $10.11 million | Q3 2024: $16.52 million | Q1 2025: $13.53 million | Q2 2025: $20.28 million | Q3 2025: $14.97 million.
- Over the full 14 years of available data (2012 to 2025), Eledon Pharmaceuticals, Inc.'s Research And Development Expense has grown by 799.1%.
- Historical annual values: Fiscal year 2025: $66.27 million | Fiscal year 2024: $51.96 million | Fiscal year 2023: $30.31 million | Fiscal year 2022: $27.08 million | Fiscal year 2021: $23.74 million | Fiscal year 2020: $6.13 million | Fiscal year 2019: $8.13 million | Fiscal year 2018: $6.82 million | Fiscal year 2017: $2.02 million | Fiscal year 2016: $3.19 million | Fiscal year 2015: $32.64 million | Fiscal year 2014: $14.58 million | Fiscal year 2013: $12.20 million | Fiscal year 2012: $7.37 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: